Genomic Architecture of IRF4 Rearrangements in Children and Adult Large B-cell Lymphomas
Large B-cell lymphoma with IRF4 rearrangement (LBCL-IRF4) predominantly affects children and young adults (CAYA) and presents as localized disease with excellent prognosis. Although most tumors harbor IRF4 rearrangements (IRF4-R), the existence of cryptic rearrangements has been suggested. Whether IRF4-R LBCL in adults represents the same biological entity remains unclear. To address this question, 35 CAYA patients diagnosed with LBCL-IRF4 and 7 adult (>40-year-old) LBCL with IRF4-R were investigated by an integrative molecular approach. Targeted sequencing structural variant analysis (SV-NGS) confirmed the IRF4-R in 84% of investigated cases. In CAYA, an enrichment (55% vs 29% in adults) of translocations involving IGH, with a breakpoint cluster 3' to IRF4 (EXOC2) was observed, including a cryptic insertion of IGHM-IGHJ5 into IRF4 locus. Novel translocations, IRF4::MIR142 in two CAYA (7%) and IRF4::BATF in one adult, were discovered. Whole-exome sequencing analysis identified unreported mutations in LBCL-IRF4 as YY1 and ZC3H12A (11% each). The high incidence of mutations affecting the B-cell receptor/NF-KB pathways in LBCL-IRF4 was confirmed in cases with diffuse component only. None of the CAYA tumors were classified by LymphGen tool. Adult IRF4-R LBCL showed higher levels of genetic complexity and a distinct mutational profile with mutations on KMT2D and DTX1 (43% each), and MYD88-L265P (29%), and were predicted as EZB or MCD (29% each). These differential genetic features were in line with different clinical presentations (extranodal involvement and advanced stage). In conclusion, IRF4-R architecture and mutational profile differ according to age, supporting that not all cases should be classified as LBCL-IRF4.
Authors
- Verónica Celis (ORCID: https://orcid.org/0009-0007-9465-0424)
- Joan E. Ramis-Zaldivar (ORCID: https://orcid.org/0000-0001-7108-7738)
- Ariadna Colmenero (ORCID: https://orcid.org/0000-0002-7966-0057)
- Jaime Verdú‐Amorós (ORCID: https://orcid.org/0000-0002-0900-0889)
- A M Shestakova
- Leonie Frauenfeld (ORCID: https://orcid.org/0000-0003-4236-5799)
- Olga Balagué (ORCID: https://orcid.org/0000-0002-5099-3675)
- Konnie M. Hebeda (ORCID: https://orcid.org/0000-0002-4181-3302)
- Sara Mato (ORCID: https://orcid.org/0000-0001-7269-2470)
- Elı́as Campo (ORCID: https://orcid.org/0000-0001-9850-9793)
- Leticia Quintanilla-Martı́nez (ORCID: https://orcid.org/0000-0001-7156-5365)
- Julia Salmerón‐Villalobos (ORCID: https://orcid.org/0000-0002-7092-9160)
- Kristian T. Schafernak (ORCID: https://orcid.org/0000-0003-3052-8925)
- Blanca González‐Farré (ORCID: https://orcid.org/0000-0002-1796-7248)
- Noelia Garcia
- Anna Montaner
- Mara Andrés (ORCID: https://orcid.org/0000-0001-8274-5724)
- R Mariani (ORCID: https://orcid.org/0000-0001-6755-0830)
- Ferran Nadeu (ORCID: https://orcid.org/0000-0003-2910-9440)
- Madhu P. Menon (ORCID: https://orcid.org/0000-0002-4075-4961)
- Itziar Salaverría (ORCID: https://orcid.org/0000-0002-2427-9822)
- Maitane Andión
- Natalia Castrejón de Anta (ORCID: https://orcid.org/0000-0002-0647-3058)
- Elaine S. Jaffe (ORCID: https://orcid.org/0000-0003-4632-0301)
- A López-Guillermo
- Francisco Llamas Gutierrez
- Carlos Aliste Santos
- Daniel Azorín
- Vicente Arredondo-Prats
- Eric Hsi
- Gabriela Gheorghe
- Socorro Maria Rodríguez-Pinilla
- Tapan Mahendra Bhavsar
Institutions
- National Institutes of Health (US)
- Hospital Sant Joan de Déu Barcelona (ES)
- St. Jude Children's Research Hospital (US)
- Mayo Clinic (US)
- Radboud University Nijmegen (NL)
- Universidade de Santiago de Compostela (ES)
- Radboud University Medical Center (NL)
- ARUP Laboratories (United States) (US)
- Hospital Clínico Universitario de Valencia (ES)
- Hospital Infantil Universitario Niño Jesús (ES)
- Hospital Clínic de Barcelona (ES)
- Leitat Technological Center (ES)
- Phoenix Children's Hospital (US)
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Washington University Medical Center (US)
- National Cancer Institute (US)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- University of Tübingen (DE)
Publication Details
- Journal
- Blood Advances
- Published
- 2026-07-16
- DOI
- https://doi.org/10.1182/bloodadvances.2026020477
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00